Tolvaptan Sodium Phosphate
托伐普坦磷酸钠
Report date: 2025/11/20 15:20:17
NME
Base Information
Drug NameTolvaptan Sodium Phosphate
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in China
Original Approved Country/Territory
Original Approved Date2022/03/28
Country/Territory
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesOtsuka Pharmaceutical Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesOtsuka Pharmaceutical Co Ltd
Inactive CompaniesFuji Yakuhin Co Ltd Toyama Factory
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A